心脏瓣膜病介入治疗的现状和未来
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

国家自然科学基金面上项目(81970325)


urrent status and future of interventional therapy for valvular heart disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】心脏瓣膜病是一种常见的心脏疾病,一旦出现症状,尤其是合并心功能不全时,预后极差。既往外科修复和置换是瓣膜病主要的有效治疗手段,但随着全球人口老龄化,高龄瓣膜病患者日益增多,退行性病变以及功能性病变是高龄瓣膜病患者的主要病因,对于这部分人群,手术风险巨大,往往不能获得外科手术机会,因此瓣膜病介入治疗逐渐受到关注和发展。本文对心脏瓣膜病介入治疗的国内外发展现状做一述评,并对其在我国发展的未来作出展望。

    Abstract:

    【Abstract】Valvular heart disease is a common heart disease, and the prognosis is poor once symptoms appear, especially when combined with cardiac failure. With the aging trend of the global population, the number of elderly valvular disease patients is increasing and degenerative diseases and functional lesions are the main causes of elderly valvular disease patients. Although surgical repair and replacement are the main effective treatment methods for valvular diseases, but for this group of people, surgical risks are very high, often cannot get the opportunity of surgery, so valvular disease intervention began to receive attention and development. In this paper, the development of interventional therapy for valvular heart disease abroad and at home are reviewed, and its future development in China is prospected.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-03-10
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司